A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. operates in the Biological Products, (No Diagnostic Substances) industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 6K | - | - | - | - | 165K |
| Net Income | -6.0M | -5.5M | -5.3M | -10M | 19M | - |
| EPS | $-5.43 | $-3.71 | $-3.76 | $-9.30 | $56.10 | $-313,450.00 |
| Free Cash Flow | 0 | -5.3M | -8.0M | -7.8M | 2.2M | -435K |
| ROIC | -2223.3% | - | -52.5% | -77.8% | -27.7% | - |
| Gross Margin | 60.0% | - | - | - | - | 69.2% |
| Debt/Equity | 0.00 | - | - | 0.04 | 0.38 | -0.04 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -6.1M | -5.7M | -5.6M | -10M | -3.1M | -1.1M |
| Operating Margin | -101379.4% | - | - | - | - | -677.7% |
| ROE | -106.6% | - | - | -77.8% | 188.0% | - |
| Shares Outstanding | 3M | 1M | 1M | 0M | 0M | 0M |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 69.2%. Total shareholder yield (buybacks) is 0.2%. At current prices, the estimated annualized return to fair value is -25.7%.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a 5-year average return on invested capital (ROIC) of -52.7%. This is below average and may indicate limited pricing power.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a market capitalization of $6M. It is classified as a small-cap stock.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.18%.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) operates in the Biological Products, (No Diagnostic Substances) industry, within the Healthcare sector.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) reported earnings per share (EPS) of $-3.71 in its most recent fiscal year.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a 5-year average gross margin of 69.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.